Clinical Trial Update: The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating the safety, dosimetry, and efficacy of the radiopharmaceutical 177Lu-FC516 in patients with prostate cancer; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 177Lu-FC516 (Lutetium-177 labeled FC516 radiopharmaceutical)

Snippet

Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd. | Conditions: Prostate Cancer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING